ShangPharma Innovation
Overview
ShangPharma Innovation is a venture capital firm and incubator that invests in the healthcare, life science, oncology, and digital health sectors. It provides funding, incubator space, and support to accelerate and facilitate pharmaceutical discovery and development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Morphic | Jun 2016 | Series A | Co-investor |
| Obsidian Therapeutics | Dec 2017 | Series A | - |
| Aprinoia Therapeutics | Jan 2018 | Series B | Co-investor |
| Evrys Bio | - | Series A Extension | Co-investor |
| Skyhawk Therapeutics | Jun 2018 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ShangPharma Innovation based?
ShangPharma Innovation is headquartered in South San Francisco, California, United States.
When was ShangPharma Innovation founded?
ShangPharma Innovation was founded in 2016.
How many portfolio companies does ShangPharma Innovation have?
ShangPharma Innovation has 7 portfolio companies in Caplight's dataset.
What are some companies in ShangPharma Innovation's portfolio?
Portfolio companies visible on Caplight include Morphic, Obsidian Therapeutics, Aprinoia Therapeutics, Evrys Bio, Skyhawk Therapeutics.
What was ShangPharma Innovation's most recent investment shown here?
ShangPharma Innovation's most recent investment in this portfolio sample was in Skyhawk Therapeutics in 2018.
What sectors does ShangPharma Innovation focus on?
ShangPharma Innovation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does ShangPharma Innovation focus on?
ShangPharma Innovation typically invests at the Early stage.
What is ShangPharma Innovation's AUM?
ShangPharma Innovation's assets under management are estimated between $0.0 and $50.0M.